GlassScriptPhysician profile
Dario Pasalic
NPI 1174985097
$537.58
in general payments reported to CMS, 2019-2025
7 companies · $89.24 in 2025
The $89.24 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.39 · 2023: $293 · 2024: $120 · 2025: $89.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $209.64 | 2024-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $137.41 | 2023 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $96.06 | 2023 | |
| Tersera Therapeutics LLC | $34.29 | 2023 | Xermelo |
| Novocure INC. | $24.79 | 2023 | Optune |
| Novartis Pharmaceuticals Corporation | $17.92 | 2022 | |
| Genentech USA, INC. | $17.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dario Pasalic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.